• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Mass Tort News

Mass Tort News

News Articles for Mass Tort Attorneys

  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us
  • Sponsorships

Zantac

Brent Wisner Comments on Zantac Judgment Dismissing Plaintiff Experts

Categories: Zantac December 7, 2022 by Christina Grube Leave a Comment

West Palm Beach County Historic Courthouse; West Palm Beach, FL Christina Grube, MTN Correspondent  (MASS TORT NEWS) Judge Robin L. Rosenberg granted the defendants summary judgment in MDL 2924 for Zantac, resulting in the dismissal of plaintiff experts. In the 341 page judgment, Rosenburg ruled that the studies of animals which plaintiff experts used to support … [Read more...] about Brent Wisner Comments on Zantac Judgment Dismissing Plaintiff Experts

Motion By Plaintiff Leadership Undermines Effectiveness of Zantac MDL?

Categories: Zantac November 15, 2022 by Christina Grube Leave a Comment

By Christina Grube Updated 11/29/22 (MASS TORT NEWS) A recent motion by Plaintiff leaders in Zantac MDL 2924 may serve to undermine the effectiveness of the MDL. In January, U.S. District Judge Robin Rosenburg approved the request by Plaintiff leadership to reduce the number of cancers from 10 to 5, removing certain cancers (breast, prostate, colorectal, kidney, and … [Read more...] about Motion By Plaintiff Leadership Undermines Effectiveness of Zantac MDL?

Baum Hedlund Sues FDA to Force Release of Agency Documents Related to ‘Flawed’ Zantac Study

Categories: Current Litigation, Zantac Tags: current litigation, zantacAugust 26, 2022 by Mass Tort News Leave a Comment

Case captioned: James E. Goetz v. U.S. Food and Drug Administration (Case 3:22-cv-04768-TSH).  August 26, 2022 - (MASS TORT NEWS) The Baum Hedlund Aristei & Goldman law firm filed a lawsuit against the U.S. Food and Drug Administration (FDA) last to compel the agency to release documents regarding an agency-sponsored study on Zantac which “has a number of alarming and … [Read more...] about Baum Hedlund Sues FDA to Force Release of Agency Documents Related to ‘Flawed’ Zantac Study

NEW MDL LITIGATION ON THE HORIZON

Categories: Elmiron, Emerging Torts, Gardasil, Zantac August 1, 2022 by Brandon Salter Leave a Comment

By Brandon Salter Michael Brady Lynch Firm August 1, 2022 (Mass Tort News) - 2022 has been a momentous year for Multi-district Litigation, particularly in pharmaceutical MDLs such as Zantac, Valsartan, Elmiron, Taxotere, Nexium & Prilosec. It is expected that some of these cases will go to trial in the year 2023; however, the best is yet to come with new … [Read more...] about NEW MDL LITIGATION ON THE HORIZON

A Forward-Looking Perspective on Mass Tort Practice

Categories: Business of Mass Torts, Emerging Torts, Zantac Tags: big pharma, business of mass torts, emerging torts, fda, zantacSeptember 22, 2021 by Mass Tort News Leave a Comment

As with most things, the future of mass torts will likely mimic its past. Cancer cases, like those associated with tobacco and asbestos in the past, are driving current and future mass tort litigation. New and ongoing litigation continues for products such as: Zantac Roundup Talc Valsartan Sunscreen PFAS Metformin CPAP With technological and scientific … [Read more...] about A Forward-Looking Perspective on Mass Tort Practice

ZANTAC MDL 2924-Recent Rulings and Overall Status

Categories: Zantac Tags: zantacJanuary 18, 2021 by Mark York Leave a Comment

Including comments by Brent Wisner, Baum Hedlund. MASS TORT NEWS January 18, 2021 Washington, DC In Re: Zantac (Ranitidine) Products Liability Litigation MDL 2924 court website JPML Initial Zantac Transfer Order, Feb. 6, 2020 By Mark A. York, Editor (MassTortNews.org) United States consumers are learning more and more that healthcare manufacturing oversight has failed … [Read more...] about ZANTAC MDL 2924-Recent Rulings and Overall Status

Zantac Litigation Overview

Categories: Current Litigation, Zantac Tags: current litigation, zantacSeptember 14, 2020 by Brenden Leydon Leave a Comment

Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases. What is Zantac/Ranitidine? Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 receptor agonists (H2 blockers). … [Read more...] about Zantac Litigation Overview

FDA Issues Recall Statement On All Zantac (Ranitidine) Products

Categories: Zantac Tags: fda, ranitidine, zantacApril 1, 2020 by Mass Tort News Leave a Comment

FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk  The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the … [Read more...] about FDA Issues Recall Statement On All Zantac (Ranitidine) Products

Primary Sidebar

Search

Stay updated

Subscribe

Sign up to receive weekly updates on the latest in Mass Tort News.

Footer

Search

Main Navigation

  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us
  • Sponsorships

Categories

Events

Trial Lawyers Summit 2022

February 16, 2022 By Mass Tort News

2021 Trial Lawyers Summit Recap

May 11, 2021 By Mark York

2021 TRIAL LAWYERS SUMMIT

May 4, 2021 By Mass Tort News

More Posts from this Category

MASS TORT NEWS

Latest Mass Tort Litigation News

Connect with MTN!

  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube

Copyright © 2023 · Mass Tort News · All Rights Reserved.